China Medicine (PINK:CHME)

GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Do you represent this company?

Learn how we can help increase your exposure to investors.

All Research Auditor trail CFO Trail Comments & Business Outlook Corporate Governance Financial Target Agreements Investor Alert Investor Presentations Notable Share Transactions

Thursday, January 7, 2010

Per a financing agreement with an investor (One Equity Partners) the Company has will have to release shares, based on a formula, to the investor if certain financial targets are not attained:

Assuming Company completes the acquisition of Jiangmen during the 2010 fiscal year.

	2011 Target	% Change	2010 Target	% Change	2009 Reported
EBITDA	$39.0 M	56.0%	$25.0 M	n/a	TBA

Assuming Company does not completes the acquisition of Jiangmen during the 2010 fiscal year.

	2011 Target	% Change	2010 Target	% Change	2009 Reported
EBITDA	$39.0 M	77.3%	$22.0 M	n/a	TBA

The EBITDA targets shall be adjusted upwards to account for expected returns from additional acquisitions that may be consummated.

The 2010 Target EBITDA is subject to a downward adjustment of US$1,000,000 if Closing occurs after January 31, 2010

Source: SEC 8K Filing (January 7, 2009, page 29).

Permalink